Cardiometabolic Health

RCT supports probiotic’s cardiometabolic health potential

27-Jul-2023 By Stephen Daniells

Dietary supplementation with a specific Lacticaseibacillus paracasei probiotic strain may improve the function of the endothelium and overall heart health in people with metabolic syndrome (MetS), says a new study.

Vitamin B12 and folic acid supplementation shows metabolic health benefits in kids – India RCT

21-Jun-2023 By Tingmin Koe

The supplementation of vitamin B12 and folic acid in toddlers has reduced their plasma concentrations of fasting total homocysteine (tHcy) – an amino acid that is linked to cardiometabolic diseases when in elevated levels.

Dietary supplements could help prevent cardiometabolic syndrome

20-Jun-2023 By Olivia DeSmit

Dietary supplements could “provide a moderate preventative value” for cardiometabolic syndrome (CMS), according to a recent review published in Frontiers in Cardiovascular Medicine.

Next-gen probiotic gets FDA no objection GRAS

02-May-2023 By Stephen Daniells

Netherlands-based Caelus Health has received a letter of no objection from the US FDA regarding the GRAS (generally recognized as safe) status for a next-generation microbe.

Personalised nutrition based on metabolism leads to better health, finds research

13-Feb-2023 By Flora Southey

For the first time, researchers have demonstrated that cardiometabolic health can be improved thanks to a personalised diet based on metabolism.

Annatto Tocotrienol plus Resveratrol may improve cardiometabolic risk in MetS: RCT

20-Dec-2022 By Stephen Daniells

A combination of delta-tocotrienol from annatto improved cardiometabolic risk factors, including central obesity and blood pressure, suggest findings from a randomized clinical study.

Meta-analysis: Some micronutrients may be better for the heart than others

15-Dec-2022 By Asia Sherman

Supplementation with some but not all micronutrients may benefit cardiometabolic health, says a new review published in the Journal of the American College of Cardiology. Others may even be bad for your heart.

FDA warns seven companies over cardiovascular disease claims

18-Nov-2022 By Hank Schultz

Seven companies have been warned by the US Food and Drug Administration over claims of treating cardiovascular disease, the Agency announced yesterday.

Enriched seafood sticks may mediate risk factors for chronic disease in obese people

21-Sep-2022 By Nicola Gordon-Seymour

Seafood sticks enriched with postbiotics and bioactive compounds may lower postprandial insulin and pulse pressure (PP), and reduce the risk of cardiometabolic disease (CMD) in abdominally obese individuals, says a new study.

Evidence suggests ginseng improves the cardiometabolic outcomes of individuals with dysglycemia

15-Jun-2022 By Nicola Gordon-Seymour

A comprehensive assessment of clinical evidence suggests ginseng improves cardiometabolic outcomes in individuals with prediabetes and type 2 diabetes mellitus (T2DM), according to researchers.

Trial extends study of chitin‐glucan benefits to subjects at cardiometabolic risk

03-Jun-2022 By Asia Sherman

Chitin-glucan, an insoluble dietary fiber extracted from the cell walls of fungi, may benefit subjects at cardiometabolic risk, according to a recent study published in Nature.